Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clostridium butyricum for perioperative intestinal function in colorectal cancer
ChiCTR2000033883Phase 4Not yet recruiting
- Sponsor
- Fudan University Shanghai Cancer Center
- Start
- Jun 2020
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of clostridium butyricum in colorectal cancer (CRC) (2 arms), sponsored by Fudan University Shanghai Cancer Center. Primary endpoints: First postoperative flatus time and Intestinal flora diversity. Planned start Jun 2020; status: not yet recruiting.
02
Drugs
clostridium butyricum
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR2000033883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033883.